THE COMPARISON OF CHONDROGENIC DIFFERENTIATION POTENTIALINHUMAN MESENCHYMAL STEM CELLS FROM MENSTRUAL BLOOD AND BONE MARROW USING ACTIVIN A AND TGF-β3

Ilona Uzielienė1, prof. ZygmuntMackevič1, dr. Daiva Bironaitė1, JaroslavDenkovskij1, Saulė Valiūnienė1, Roma Grinienė1, dr.Eiva Bernotienė1

1 DepartmentforRegenerativemedicine, Centre forInnovativemedicine, Lithuania

Human mesenchymal stem cells (MSC) are multipotent cells found in many tissues. These cells generated a great deal of interest in regenerative medicine due to their high potential to differentiate into several lineages including osteoblasts, chondroblasts and adipocytes [1]. Articular cartilage due to its low capacity for self-repair is highly susceptible to degradative diseases such as osteoarthritis. Since cartilage is composed primarily of chondrocytes distributed in a specialized extracellular matrix, MSC with theirchondrogenic differentiation potential appear to be ideally suited for therapeutic use in cartilage regeneration [2]. Although the entire bond of molecular mechanisms that control chondrogenic differentiation in MSC is still unclear, some of the factors that help cell differentiation to occur have been developed. For instance,transforming growth factor β (TGF-β) was identified as a major cartilage-inducing factor and is always used for a qualitativechondrogenic response in cells [3]. Nowadays several literature sources suggest that a member of the TGF-β superfamily activin A also appears to play a pivotal role in the early stages of MSC chondrogenesis and osteogenesis, while inhibiting adipogenesis. It has been shown that activin A is necessary for the maintenance of self-renewal and pluripotency of MSC. Besides, activin A takes place in the regulation of women menstrual cycle and the uterus endodermis regeneration [4]. Since menstrual blood is enriched witheasy accessible MSC [5], wehypothesized that activin A may play a crucial role in chondrogenicdifferention of these MSC.

The aim of this study was to compare human mesenchymal stem cells isolated from two different tissues menstrual blood (MenSCs) and bone marrow (BMSCs) and their potential to differentiate into chondrogenic lineage using two differentiation stimulation factors -activin A and TGF-β3. Firstly, we isolated the cells from 6 different healthy donors (3 – bone marrow donors; 3 – menstrual blood donors). Secondly, we compared these cells by different stem cell and chondrogenicdifferentiation surface markers (CD90, CD73, CD105, CD44, CD45, CD14, CD36, CD55, CD54, CD63, CD271, CD106, CD34, CD49a, CD49e, CD49c, CD338, ABCC1, CD10, Stro1, Notch1, CD221, CD133, Hla-DR) by flow cytometry and examined their proliferation capacity using proliferation kit CCK-8. Moreover, we analyzed the potential of MenSCs and BMSCs to differentiate into two MSC lineages – adipogenic and osteogenic. Adipogenic differentiation was assessed using Oil-Red staining, whereas osteogenic differentiation was assessed using alizarin red staining. Finally, chondrogenic differentiation was evaluated by histochemistry, staining cell pellets with safranin O and collagen II antibodies.

The results suggest that in contrast to BMSCs, MenSCs exhibited higher expression of CD10, CD49a and Notch1, and higher proliferative capacity. The potential ofadipogenic differentiation of MenSCs was weaker than BMSCs, and osteogenic differentiation capacity was positive and similar for both – MenSCs and BMSCs. Chondrogenic differentiation was also similar with TGF-β3 for both cell types, whileactivinAinduced chondrogenic differentiation was remarkably higher inMenSCsthan in BMSCs.

Even though several literature sources claimed that activin A is not a suitable alternative to TGF-β3 for chondrogenic differentiation of MSC [6], our results demonstrate that chondrogenic differentiation stimulated by activin A was positive for both tissue MSC, especially for MenSCs. In conclusion, to obtain stable cartilage formation, different cell types may require different growth factors inducing chondrogenic response in cells. Our comparative analysis implicates the significance of activin A as a functional growth factor for the induction of chondrogenic differentiation in MSC, suggesting MenSC as a perspective source for stimulation of cartilage repair and that activin A is implicated in their differentiation.


[1] Musumeci G, Castrogiovanni P, Leonardi R, et al. New perspectives for articular cartilage repair treatment through tissue engineering: Acontemporary review. World Journal of Orthopedics. 2014.

[2] Oldershaw RA. Cell sources for the regeneration of articular cartilage: the past, the horizon and the future. International Journal of Experimental Pathology. 2012; 93, 389–400.

[3] Tang J, Zhu X, Zhao J, Fung M, Li Y, Gao Z, Yan S, Li X, Ji X, Su F, Li1 Z. Tissue Transglutaminase-Regulated Transformed Growth Factor-β1 in the Parasite Links Schistosoma japonicum Infection with Liver Fibrosis. Mediators of Inflammation 2015; 11.

[4] Djouad F, Jackson WM, Bobick BE, Janjanin S, Song Y, Huang GTJ, Tuan RS. Activin A expression regulates multipotency of mesenchymal progenitor cells. Stem Cell Research & Therapy 2010; 1:11.

[5] Meng X, Ichim TE, Zhong J. Endometrial regenerative cells: A novel stem cell population. Journal of Translational Medicine. 2007; 5:57.

[6] Kroon LMG, Davidson ENB, Narcisi R. Activin and Nodal Are Not Suitable Alternatives to TGFβ for Chondrogenic Differentiation of Mesenchymal Stem Cells. Cartilage. 2016; 1-7.